Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam.
Chen, Maylee
Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam. [electronic resource] - Drug metabolism and disposition: the biological fate of chemicals Dec 2006 - 2079-82 p. digital
Publication Type: Clinical Trial; Journal Article
0090-9556
10.1124/dmd.106.011742 doi
Administration, Oral
Adolescent
Adult
Cross-Over Studies
Cytochrome P-450 CYP3A Inhibitors
Enzyme Inhibitors--pharmacology
Female
Humans
Ketoconazole--pharmacology
Male
Midazolam--blood
Middle Aged
Drug-metabolizing enzyme inhibition by ketoconazole does not reduce interindividual variability of CYP3A activity as measured by oral midazolam. [electronic resource] - Drug metabolism and disposition: the biological fate of chemicals Dec 2006 - 2079-82 p. digital
Publication Type: Clinical Trial; Journal Article
0090-9556
10.1124/dmd.106.011742 doi
Administration, Oral
Adolescent
Adult
Cross-Over Studies
Cytochrome P-450 CYP3A Inhibitors
Enzyme Inhibitors--pharmacology
Female
Humans
Ketoconazole--pharmacology
Male
Midazolam--blood
Middle Aged